1. A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study. Issue 4 (21st March 2019) Authors: Buckley, Sarah A.; Percival, Mary-Elizabeth; Othus, Megan; Halpern, Anna B.; Huebner, Emily M.; Becker, Pamela S.; Shaw, Carole; Shadman, Mazyar; Walter, Roland B.; Estey, Elihu H. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 4(2019) Page Start: 1023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A model for prediction of FLT3‐ITD and NPM1 (without FLT3‐ITD) positivity in patients with newly diagnosed acute myeloid leukaemia. (6th July 2013) Authors: Ostronoff, Fabiana; Othus, Megan; Kantarjian, Hagop M.; Meshinchi, Soheil; Ravandi, Farhad; Hendrie, Paul C.; Faderl, Stefan; Becker, Pamela S.; Cortes, Jorge E.; Pagel, John M.; Petersdorf, Stephen H.; Godwin, John E.; Willman, Cheryl L.; Pierce, Sherry A.; List, Alan F.; Sandhu, Ravinder K.; Wa... Journal: British journal of haematology Issue: Volume 163:Number 1(2013:Oct.) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I/II study of oral clofarabine plus low‐dose cytarabine in previously treated acute myeloid leukaemia and high‐risk myelodysplastic syndrome patients at least 60 years of age. (8th April 2015) Authors: Buckley, Sarah A.; Mawad, Raya; Gooley, Ted A.; Becker, Pamela S.; Sandhu, Vicky; Hendrie, Paul; Scott, Bart L.; Wood, Brent L.; Walter, Roland B.; Smith, Kelly; Dean, Carol; Estey, Elihu H.; Pagel, John M. Journal: British journal of haematology Issue: Volume 170:Number 3(2015:Aug.) Page Start: 349 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Issue 2 (28th January 2023) Authors: Assouline, Sarit; Michaelis, Laura C.; Othus, Megan; Hay, Annette E.; Walter, Roland B.; Jacoby, Meagan A.; Schroeder, Mark A.; Uy, Geoffrey L.; Law, Lisa Y.; Cheema, Faisal; Sweet, Kendra L.; Asch, Adam S.; Liu, Jijun (Jane); Moseley, Anna B.; Maher, Tracy; Kingsbury, Laura L.; Fang, Min; Radich... Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Activity of the oral mitogen‐activated protein kinase kinase inhibitor trametinib in RAS‐mutant relapsed or refractory myeloid malignancies. Issue 12 (18th March 2016) Authors: Borthakur, Gautam; Popplewell, Leslie; Boyiadzis, Michael; Foran, James; Platzbecker, Uwe; Vey, Norbert; Walter, Roland B.; Olin, Rebecca; Raza, Azra; Giagounidis, Aristoteles; Al‐Kali, Aref; Jabbour, Elias; Kadia, Tapan; Garcia‐Manero, Guillermo; Bauman, John W.; Wu, Yuehui; Liu, Yuan; Schramek,... Journal: Cancer Issue: Volume 122:Issue 12(2016) Page Start: 1871 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia. (24th May 2018) Authors: Michaelis, Laura C.; Klepin, Heidi D.; Walter, Roland B. Journal: Expert opinion on pharmacotherapy Issue: Volume 19:Number 8(2018) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia. Issue 12 (14th October 2020) Authors: Godwin, Colin D.; Bates, Olivia M.; Jean, Sae Rin; Laszlo, George S.; Garling, Eliotte E.; Beddoe, Mary E.; Cardone, Michael H.; Walter, Roland B. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia. Issue 12 (14th October 2020) Authors: Godwin, Colin D.; Bates, Olivia M.; Jean, Sae Rin; Laszlo, George S.; Garling, Eliotte E.; Beddoe, Mary E.; Cardone, Michael H.; Walter, Roland B. Journal: Leukemia & lymphoma Issue: Volume 61:Issue 12(2020) Page Start: 2990 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?. Issue 4 (2nd April 2016) Authors: Rashidi, Armin; Walter, Roland B. Journal: Expert review of hematology Issue: Volume 9:Issue 4(2016) Page Start: 335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Associations between allergies and risk of hematologic malignancies: Results from the VITamins and lifestyle cohort study. Issue 12 (22nd November 2013) Authors: Shadman, Mazyar; White, Emily; De Roos, Anneclaire J.; Walter, Roland B. Journal: American journal of hematology Issue: Volume 88:Issue 12(2013:Dec.) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗